OBJECTIVE	This study examined changes in bone formation and resorption after infliximab induction and associations between bone biomarkers , linear growth , and disease activity ( Pediatric Crohn 's Disease Activity Index [ PCDAI ] ) after 54 weeks of infliximab therapy .\